These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24003080)

  • 1. Transcatheter aortic valve replacement (TAVR) in patients with systemic autoimmune diseases.
    Fuentes-Alexandro S; Escarcega R; Garcia-Carrasco M; Cervera R
    Lupus; 2013 Nov; 22(13):1433-4. PubMed ID: 24003080
    [No Abstract]   [Full Text] [Related]  

  • 2. Conventional AVR and TAVR in patients with autoimmune disease.
    Keeling IM; Maier RM; Dapunt OE
    Lupus; 2015 Jan; 24(1):107-8. PubMed ID: 25193330
    [No Abstract]   [Full Text] [Related]  

  • 3. Transcatheter aortic valve replacement for advanced valvular disease in active SLE and APS.
    Bert JS; Abdullah M; Dahle TG; Gertner E
    Lupus; 2013 Sep; 22(10):1046-9. PubMed ID: 23884983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the best approach in a patient with a failed aortic bioprosthetic valve: transcatheter aortic valve replacement or redo aortic valve replacement?
    Tourmousoglou C; Rao V; Lalos S; Dougenis D
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):837-43. PubMed ID: 25754372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coexistence of severe aortic insufficiency and systemic lupus erythematosis with antiphospholipid syndrome--case report].
    Rynkun D; Kotliński Z; Zieliński T; Jedryka-Góral A
    Pol Arch Med Wewn; 1994 Dec; 92(6):525-31. PubMed ID: 7716057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortic valve replacement for Libman-Sacks endocarditis.
    Keenan JB; Rajab TK; Janardhanan R; Larsen BT; Khalpey Z
    BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27702929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional aortic valve replacement: still a feasible option in the transcatheter aortic valve implantations era?
    Cremer J
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1253-4. PubMed ID: 22398464
    [No Abstract]   [Full Text] [Related]  

  • 8. Interventions to reduce major vascular complications of TAVR.
    Barbanti M; Webb JG
    Expert Rev Cardiovasc Ther; 2013 Jul; 11(7):891-901. PubMed ID: 23895032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foreword. An update on transcatheter aortic valve replacement.
    Rahimtoola SH
    Curr Probl Cardiol; 2013 Jul; 38(7):243. PubMed ID: 23746945
    [No Abstract]   [Full Text] [Related]  

  • 10. Aortic valve replacement after previous coronary artery bypass grafting in a patient with antiphospholipid syndrome.
    Sakaguchi G; Minami K; Nakayama S; Tsuneyoshi H
    Jpn J Thorac Cardiovasc Surg; 1998 Mar; 46(3):257-9. PubMed ID: 9584474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic or mitral valve replacement in systemic lupus erythematosus.
    Alameddine AK; Schoen FJ; Yanagi H; Couper GS; Collins JJ; Cohn LH
    Am J Cardiol; 1992 Oct; 70(9):955-6. PubMed ID: 1529955
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of wait times on the effectiveness of transcatheter aortic valve replacement in severe aortic valve disease: a discrete event simulation model.
    Wijeysundera HC; Wong WW; Bennell MC; Fremes SE; Radhakrishnan S; Peterson M; Ko DT
    Can J Cardiol; 2014 Oct; 30(10):1162-9. PubMed ID: 25047363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter aortic valve replacement scores well in trial. Research supports the continued development of the minimally invasive approach to replacing the largest of the heart valve.
    Heart Advis; 2011 Jun; 14(6):3. PubMed ID: 23189366
    [No Abstract]   [Full Text] [Related]  

  • 14. Prosthesis-patient mismatch in aortic valve disease: surgical versus transcatheter valve replacement.
    Pibarot P
    EuroIntervention; 2011 Oct; 7(6):660-1. PubMed ID: 21986325
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitral stenosis and regurgitation with systemic lupus erythematosus and antiphospholipid antibody syndrome.
    Hasegawa R; Kitahara H; Watanabe K; Kuroda H; Amano J
    Jpn J Thorac Cardiovasc Surg; 2001 Dec; 49(12):711-3. PubMed ID: 11808093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy after transcatheter aortic valve replacement.
    Hough A; Woods D
    JAMA; 2014 Mar; 311(12):1249-50. PubMed ID: 24668109
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithrombotic therapy after transcatheter aortic valve replacement--reply.
    Mack M
    JAMA; 2014 Mar; 311(12):1250-1. PubMed ID: 24668110
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials on transcatheter aortic valve implantation cannot be compared because of inconsistent endpoints.
    Taylor J
    Eur Heart J; 2011 Jan; 32(2):125-6. PubMed ID: 21239420
    [No Abstract]   [Full Text] [Related]  

  • 19. Expert opinion: MDCT aortic root measurements for transcatheter aortic valve implantation.
    Boiselle PM; Abbara S; Blanke P; Leipsic JA; Sundaram B; Quint LE
    J Thorac Imaging; 2012 May; 27(3):140. PubMed ID: 22508092
    [No Abstract]   [Full Text] [Related]  

  • 20. Transcatheter valve-in-valve implantation for the treatment of stentless aortic valve dysfunction.
    Rodés-Cabau J; Dumont E; Doyle D; Lemieux J
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):246-8. PubMed ID: 19783014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.